Mycophenolic acid
Mycophenolic acid agents: is enteric coating the answer?
... Twelve-month evalu- ation of the clinical pharmacokinetics of total and free mycophenolic acid and its glucuronide metabolites in renal allograft recipients on low dose tacrolimus in c[r] ...
9
Original Article Delineation of biological and molecular mechanisms underlying the diverse anticancer activities of mycophenolic acid
... of mycophenolic acid (MPA) which has been wide- ly used for the prevention of acute graft rejection, is a potent inhibitor of inosine monophosphate dehydrogenase (IMPDH) that is up-regulated in many tumors ...
7
Nanogel based delivery of mycophenolic acid ameliorates systemic lupus erythematosus in mice
... The ability to selectively inactivate immune cells with immunosuppressants is a much sought-after modality for the treatment of systemic lupus erythematosus and autoimmunity in general. Here, we designed and tested a ...
10
To Determine Whether Mycophenolic Acid Area under the Curve Correlates with Disease Activity In Pediatric Lupus Nephritis Patients Treated with Mycophenolate Mofetil
... Mycophenolate mofetil is a relatively new drug which has been used routinely in the prophylaxis against graft rejection and in its treatment in the post renal transplant patients. Mycophenolate mofetil (MMF) is ...
80
A novel and Rapid LC–MS/MS assay for the Determination of Mycophenolate and Mycophenolic Acid in Human Plasma
... formic acid buffer (80:20, v/v) pumped at a flow rate of ...and mycophenolic acid were well within the acceptance criteria specified in the US FDA and EMEA ...and mycophenolic acid in ...
8
Mycophenolic acid counteracts B cell proliferation and plasmablast formation in patients with systemic lupus erythematosus
... MMF is a pro-drug of mycophenolic acid (MPA). MPA reversibly inhibits inosine monophosphate dehydrogenase (IMPDH). MPA preferentially inhibits type-II-IMPDH that is upregulated in activated lymphocytes ...
14
Mycophenolic acid formulations in adult renal transplantation – update on efficacy and tolerability
... pathways. Mycophenolic acid (MPA) blocks the key enzyme inosine monophosphate dehydrogenase and the production of guanosine nucleotides required for DNA ...
12
Differential Sensitivities of Fast- and Slow-Cycling Cancer Cells to Inosine Monophosphate Dehydrogenase 2 Inhibition by Mycophenolic Acid
... As uncontrolled cell proliferation requires nucleotide biosynthesis, inhibiting enzymes that mediate nucleotide biosynthesis constitutes a rational approach to the management of oncological diseases. In practice, ...
11
Comparison of PETINIA and LC-MS/MS for determining plasma mycophenolic acid concentrations in Japanese lung transplant recipients
... (HPLC-UV), liquid chromatography-tandem mass spectrometry (LC-MS/MS), or automated immunoas- says [3, 4]. Although immunoassays are widely used in clinical laboratories due to ease of adopting such methods on automated ...
5
mTOR inhibitor versus mycophenolic acid as the primary immunosuppression regime combined with calcineurin inhibitor for kidney transplant recipients: a meta-analysis
... MPA, mycophenolic acid, MMF, myco- phenolate mofetil, CellCept (Roche, Basel, Switzerland), EC-MPS, enteric-coated mycophenolate sodium, calcine- urin inhibitor, CNI, ciclosporin/cyclosporine, Neoral, ...
13
Mycophenolic Acid Absorption Profiles in Patients with Kidney or Combined Pancreas Kidney Transplantation
... immunosuppressant mycophenolic acid (MPA), has replaced azathioprine in cyclosporine A (CsA) or tacrolimus (Tac)-based immunosuppression for renal transplant patients, but also after liver, heart, and ...
7
Isolation of Mycophenolic Acid by Optimization of Downstream Process Parameters using Statistical Approach
... Mycophenolic acid (MPA) is a secondary metabolite produced by Penicillium brevicompactum which has antibiotic and immunosuppressive ...for mycophenolic acid ...
5
Usefulness of limited sampling strategy for mycophenolic acid area under the curve considering postoperative days in living-donor renal transplant recipients with concomitant prolonged-release tacrolimus
... Mycophenolate mofetil (MMF), a prodrug of the im- munosuppressant mycophenolic acid (MPA), has been widely used for the prevention of rejection in solid organ transplant patients [1–3]. MMF is administered ...
7
Differential proteome analysis of human embryonic kidney cell line (HEK-293) following mycophenolic acid treatment
... placed in developing solution (6% sodium carbonate, 0.018526% formaldehyde and 6% sodium thiosulfate) until standard marker stained completely and adequate spots were visualized. Gels were scanned with a gel Cano scan ...
12
Study on the association of UGT1A9 gene c.98T>C polymorphism and mycophenolic acid plasma levels in renal transplant patients.
... The aim of the present study was to investigate whether there is an association of allelic variants or genotypes of UGT1A9 c.98T>C polymorphism (rs72551330; g.87289T>C) with pl[r] ...
9
Mycophenolic acid AUC in Thai kidney transplant recipients receiving low dose mycophenolate and its association with<em> UGT2B7</em> polymorphisms
... lic acid (MPA), acts by inhibiting inosine monophosphate dehydrogenase enzyme (IMPDH), which mediates the synthesis of purine and therefore controls lymphocyte ...
7
Simultaneous Spectrophotometric Determination of Mycophenolate Mofetil and Its Active Metabolite in Human Plasma Using Chemometrics Methods
... immunosuppressant- mycophenolic acid, (4E)-6-(4- Hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzo- furan-5-yl)-4-methylhex-4-enoic acid (MPA) has been approved for maintenance immunosuppressive ...
10
Original Article Estimation of optimal minimum dosage of mycophenolate mofetil in children with various glomerular diseases
... nephritis [9]. MMF has also been recommend- ed in the 2012 KDIGO Guidelines [10]. MMF usage enables the reduction or withdrawal of steroids reducing their toxicity in the acute phase. MMF is also suitable for long-term ...
11
DRUG RELATED PROBLEM ASSOCIATED WITH THE TREATMENT FOR SEVERE ANEMIA WITH KIDNEY TRANSPLANTATION'S HISTORY IN PGI CIKINI HOSPITAL
... of mycophenolic acid in the blood and the effects of mycophenolic acid (Myfortic) ...of mycophenolic acid. Using mycophenolic acid (Mycophenolic) on an empty ...
6
Index Catalog // Carolina Digital Repository
... immunosuppressive agent mycophenolic acid (MPA; 1,3-dihydro-4-hydroxy-6- methoxy-7-methyl-3-oxo-5-isobenzylfuranyl-4-methyl-4-hexenoate, Figure 1.1). MPA is a substrate for uridine diphosphate ...
250